Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · IEX Real-Time Price · USD
1.129
-0.011 (-0.96%)
Jul 22, 2024, 10:48 AM EDT - Market open
Enzo Biochem Employees
As of July 31, 2023, Enzo Biochem had 190 total employees, including 179 full-time and 11 part-time employees. The number of employees decreased by 330 or -63.46% compared to the previous year.
Employees
190
Change (1Y)
-330
Growth (1Y)
-63.46%
Revenue / Employee
$24,847
Profits / Employee
$235,437
Market Cap
57.89M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Rockwell Medical | 237 |
Neuronetics | 203 |
Allakos | 131 |
Adlai Nortye | 127 |
Mural Oncology | 117 |
ProPhase Labs | 113 |
VolitionRx | 110 |
InspireMD | 66 |
ENZ News
- 5 weeks ago - Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments - GlobeNewsWire
- 7 months ago - ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE - GlobeNewsWire
- 9 months ago - Steven J. Pully Appointed to Enzo Biochem's Board of Directors - GlobeNewsWire
- 11 months ago - Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO - GlobeNewsWire
- 1 year ago - Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp - GlobeNewsWire
- 1 year ago - Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results - GlobeNewsWire